Nanobiotix (NBTX) Stock Statistics & Valuation Metrics

Nanobiotix has a market cap or net worth of $153.71M. The enterprise value is ―.

Nanobiotix has 47,133,327 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nanobiotix’s return on equity (ROE) is 21.53 and return on invested capital (ROIC) is -54.77%.

The current PE Ratio of Nanobiotix is -6.10. Nanobiotix’s PEG ratio is 0.18.

In the last 12 months, Nanobiotix had revenue of 36.21M and earned -39.70M in profits. Earnings per share was -1.08.

In the last 12 months, operating cash flow was -1.04M and capital expenditures -494.00K, giving a free cash flow of -1.53M billion.

Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―

Nanobiotix upcoming earnings date is May 14, 2025, TBA Not Confirmed.

Nanobiotix as a current ratio of 1.75, with Debt / Equity ratio of -225.78%

In the past 12 months, Nanobiotix has paid 120.00K in taxes.

Nanobiotix EV to EBITDA ratio is -9.18, with an EV/FCF ratio of -16.97.

Nanobiotix has $66.33M in cash and marketable securities with €1.43M in debt, giving a net cash position of -$17.17M billion.

Gross margin is 100.00%, with operating margin of -73.96%, and net profit margin of -109.64%.

The average price target for Nanobiotix is $6.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy